United States Biotechnology & Medical Research

Oruka Therapeutics Inc (ORKA)

Track

Track

Oruka Therapeutics Inc. experienced significant insider trading activity recently, with executives executing fifty-six sales totaling over 649 million dollars. These divestments occurred following the latest earnings report. Despite a strong ninety-day stock performance, leadership consistently offloaded shares through planned programs, reflecting a net negative insider sentiment during this period of high market valuation.
Ticker: ORKA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Oruka Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
147.63
Quantity 83,848 -26.8%
Value US$3,734,655
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.70
Quantity 48,242 -9.0%
Value US$3,479,468
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
131.52
Quantity 42,517 -32.3%
Value US$3,217,679
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
109.65
Quantity 1,000 -2.3%
Value US$100,000
0.6
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
111.14
Quantity 1,000 -11.0%
Value US$100,000
0.6
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
110.00
Quantity 1,000 -20.9%
Value US$100,000
0.6
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
109.11
Quantity 1,000 -18.8%
Value US$100,000
0.6
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
107.97
Quantity 1,000 -21.3%
Value US$100,000
0.6
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
107.14
Quantity 1,000 -13.1%
Value US$100,000
0.6
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
106.05
Quantity 1,000 -4.4%
Value US$100,000
0.6
PAUL QUINLAN Officer Officer
Transaction date
Proposed sale
Price
108.12
Quantity 1,000
Value US$100,000
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
108.46
Quantity 1,000 -13.3%
Value US$100,000
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
107.71
Quantity 1,000 -10.8%
Value US$100,000
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
106.63
Quantity 1,000 -6.0%
Value US$100,000
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
105.57
Quantity 1,000 -9.2%
Value US$100,000
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
104.67
Quantity 1,000 -8.3%
Value US$100,000
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
87.25
Quantity 300 -0.9%
Value US$26,176
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
86.68
Quantity 3,803 -10.3%
Value US$329,630
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
85.86
Quantity 2,497 -6.4%
Value US$214,385
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
84.37
Quantity 400 -1.0%
Value US$33,746
0.6
JOANA GONCALVES Officer Officer
Transaction date
Proposed sale
Price
87.47
Quantity 21,000
Value US$1,836,870
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
85.63
Quantity 300 -1.9%
Value US$25,690
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
84.90
Quantity 5,656 -26.6%
Value US$480,201
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
84.26
Quantity 3,743 -15.0%
Value US$315,369
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
83.07
Quantity 300 -1.2%
Value US$24,920
0.6
Arjun Agarwal Officer Officer
Transaction date
Proposed sale
Price
86.79
Quantity 28,588
Value US$2,481,153
3.3
Fairmount Healthcare Fund II L.P. Director, 10% Stockholder Non-Executive Director Large shareholder
Transaction date
Proposed sale
Price
84.43
Quantity 3,553,410
Value US$300,014,406
3.3
Fairmount Funds Management LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
84.43
Quantity 3,553,410 -75.8%
Value US$300,014,406
0.6
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
95.47
Quantity 500 -0.2%
Value US$47,736
0.6
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
94.75
Quantity 2,263 -0.9%
Value US$214,410
0.6
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
93.85
Quantity 2,237 -0.9%
Value US$209,933
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
82.15
Quantity 699 -4.4%
Value US$57,419
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
82.15
Quantity 699 -4.4%
Value US$57,419
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
80.01
Quantity 888 -5.3%
Value US$71,049
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
80.01
Quantity 888 -5.3%
Value US$71,049
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Sale
Price
69.69
Quantity 395 -2.3%
Value US$27,528
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Sale
Price
69.69
Quantity 947 -2.8%
Value US$65,996
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
70.62
Quantity 300 -0.9%
Value US$21,187
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
69.42
Quantity 5,064 -13.0%
Value US$351,547
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
68.38
Quantity 1,636 -4.0%
Value US$111,876
0.6
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Sale
Price
69.69
Quantity 1,729 -0.2%
Value US$120,494
0.6
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Sale
Price
69.69
Quantity 600 -0.3%
Value US$41,814
0.6
Quinlan Paul T General Counsel Officer
Transaction date
Sale
Price
69.69
Quantity 733 -2.3%
Value US$51,083
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
70.34
Quantity 3,260 -15.9%
Value US$229,306
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
69.85
Quantity 4,340 -17.4%
Value US$303,154
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
68.34
Quantity 1,859 -6.9%
Value US$127,048
Dambkowski Carl Non-Executive Director
Transaction date
Planned sale
Price
70.11
Quantity 12,583 -24.5%
Value US$882,182
Dambkowski Carl Non-Executive Director
Transaction date
Planned sale
Price
70.11
Quantity 12,583 -24.5%
Value US$882,182
Dambkowski Carl Non-Executive Director
Transaction date
Planned sale
Price
70.13
Quantity 22,417 -30.4%
Value US$1,572,201
CARL DAMBKOWSKI Director Non-Executive Director
Transaction date
Proposed sale
Price
64.03
Quantity 35,000
Value US$2,241,050
CARL DAMBKOWSKI Director Non-Executive Director
Transaction date
Proposed sale
Price
64.03
Quantity 35,000
Value US$2,241,050
Dambkowski Carl Non-Executive Director
Transaction date
Planned sale
Price
59.97
Quantity 13,235 -15.2%
Value US$793,662
Dambkowski Carl Non-Executive Director
Transaction date
Planned sale
Price
59.10
Quantity 53,447 -38.1%
Value US$3,158,910
Dambkowski Carl Non-Executive Director
Transaction date
Planned sale
Price
58.43
Quantity 38,318 -21.4%
Value US$2,238,794
CARL DAMBKOWSKI Director Non-Executive Director
Transaction date
Proposed sale
Price
60.67
Quantity 105,000
Value US$6,370,350
CARL DAMBKOWSKI Director Non-Executive Director
Transaction date
Proposed sale
Price
60.67
Quantity 105,000
Value US$6,370,350
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
61.16
Quantity 700 -4.1%
Value US$42,812
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
60.34
Quantity 800 -4.5%
Value US$48,269
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
59.19
Quantity 4,600 -20.4%
Value US$272,260
0.6
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
58.34
Quantity 4,190 -15.7%
Value US$244,465
0.6
ARJUN AGARWAL Officer Officer
Transaction date
Proposed sale
Price
61.93
Quantity 22,206
Value US$1,375,218
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
63.52
Quantity 100 -0.3%
Value US$6,352
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
62.42
Quantity 2,100 -5.9%
Value US$131,088
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
61.56
Quantity 4,800 -11.9%
Value US$295,495
0.6
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
68.48
Quantity 100 -0.0%
Value US$6,848
0.6
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
67.16
Quantity 200 -0.1%
Value US$13,431
0.6
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
66.06
Quantity 400 -0.2%
Value US$26,422
0.6
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
65.10
Quantity 300 -0.1%
Value US$19,530
0.6
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
64.15
Quantity 1,800 -0.8%
Value US$115,468
0.6
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
62.58
Quantity 2,200 -0.9%
Value US$137,685
0.6
LAURA SANDLER Officer Officer
Transaction date
Proposed sale
Price
68.41
Quantity 10,000
Value US$684,100
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
67.38
Quantity 500 -1.5%
Value US$33,692
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
66.56
Quantity 2,273 -6.3%
Value US$151,301
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
65.73
Quantity 4,227 -10.5%
Value US$277,837
0.6
JOANA GONCALVES Officer Officer
Transaction date
Proposed sale
Price
67.06
Quantity 21,000
Value US$1,408,260
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-17 2026-08-17 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
83,848 -26.8%
147.63
US$3,734,655 		83,848 -26.8% 147.63 US$3,734,655
2026-08-17 2026-08-17 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
48,242 -9.0%
18.70
US$3,479,468 		48,242 -9.0% 18.70 US$3,479,468
2026-08-17 2026-08-17 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
42,517 -32.3%
131.52
US$3,217,679 		42,517 -32.3% 131.52 US$3,217,679
2026-08-17 2026-08-17 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
1,000 -2.3%
109.65
US$100,000 		1,000 -2.3% 109.65 US$100,000
2026-08-14 2026-08-14 PlS Planned sale
0.6
Quinlan Paul T

General Counsel

Officer
1,000 -11.0%
111.14
US$100,000 		1,000 -11.0% 111.14 US$100,000
2026-08-14 2026-08-14 PlS Planned sale
0.6
Quinlan Paul T

General Counsel

Officer
1,000 -20.9%
110.00
US$100,000 		1,000 -20.9% 110.00 US$100,000
2026-08-14 2026-08-14 PlS Planned sale
0.6
Quinlan Paul T

General Counsel

Officer
1,000 -18.8%
109.11
US$100,000 		1,000 -18.8% 109.11 US$100,000
2026-08-14 2026-08-14 PlS Planned sale
0.6
Quinlan Paul T

General Counsel

Officer
1,000 -21.3%
107.97
US$100,000 		1,000 -21.3% 107.97 US$100,000
2026-08-14 2026-08-14 PlS Planned sale
0.6
Quinlan Paul T

General Counsel

Officer
1,000 -13.1%
107.14
US$100,000 		1,000 -13.1% 107.14 US$100,000
2026-08-14 2026-08-14 PlS Planned sale
0.6
Quinlan Paul T

General Counsel

Officer
1,000 -4.4%
106.05
US$100,000 		1,000 -4.4% 106.05 US$100,000
2026-08-14 2026-08-14 PrS Proposed sale
0.6
PAUL QUINLAN

Officer

Officer
1,000
108.12
US$100,000 		1,000 108.12 US$100,000
2026-08-14 2026-08-13 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -13.3%
108.46
US$100,000 		1,000 -13.3% 108.46 US$100,000
2026-08-14 2026-08-13 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -10.8%
107.71
US$100,000 		1,000 -10.8% 107.71 US$100,000
2026-08-14 2026-08-13 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -6.0%
106.63
US$100,000 		1,000 -6.0% 106.63 US$100,000
2026-08-14 2026-08-13 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -9.2%
105.57
US$100,000 		1,000 -9.2% 105.57 US$100,000
2026-08-14 2026-08-13 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -8.3%
104.67
US$100,000 		1,000 -8.3% 104.67 US$100,000
2026-07-15 2026-07-15 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
300 -0.9%
87.25
US$26,176 		300 -0.9% 87.25 US$26,176
2026-07-15 2026-07-15 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
3,803 -10.3%
86.68
US$329,630 		3,803 -10.3% 86.68 US$329,630
2026-07-15 2026-07-15 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
2,497 -6.4%
85.86
US$214,385 		2,497 -6.4% 85.86 US$214,385
2026-07-15 2026-07-15 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
400 -1.0%
84.37
US$33,746 		400 -1.0% 84.37 US$33,746
2026-07-15 2026-07-15 PrS Proposed sale
0.6
JOANA GONCALVES

Officer

Officer
21,000
87.47
US$1,836,870 		21,000 87.47 US$1,836,870
2026-07-13 2026-07-13 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
300 -1.9%
85.63
US$25,690 		300 -1.9% 85.63 US$25,690
2026-07-13 2026-07-13 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
5,656 -26.6%
84.90
US$480,201 		5,656 -26.6% 84.90 US$480,201
2026-07-13 2026-07-13 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
3,743 -15.0%
84.26
US$315,369 		3,743 -15.0% 84.26 US$315,369
2026-07-13 2026-07-13 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
300 -1.2%
83.07
US$24,920 		300 -1.2% 83.07 US$24,920
2026-07-13 2026-07-13 PrS Proposed sale
0.6
Arjun Agarwal

Officer

Officer
28,588
86.79
US$2,481,153 		28,588 86.79 US$2,481,153
2026-07-01 2026-07-01 PrS Proposed sale
3.3
Fairmount Healthcare Fund II L.P.

Director, 10% Stockholder

Non-Executive Director Large shareholder
3,553,410
84.43
US$300,014,406 		3,553,410 84.43 US$300,014,406
2026-07-01 2026-07-01 S Sale
3.3
Fairmount Funds Management LLC
Non-Executive Director Large shareholder
3,553,410 -75.8%
84.43
US$300,014,406 		3,553,410 -75.8% 84.43 US$300,014,406
2026-07-01 2026-07-01 PlS Planned sale
0.6
Sandler Laura Lee

Chief Operating Officer

Officer
500 -0.2%
95.47
US$47,736 		500 -0.2% 95.47 US$47,736
2026-07-01 2026-07-01 PlS Planned sale
0.6
Sandler Laura Lee

Chief Operating Officer

Officer
2,263 -0.9%
94.75
US$214,410 		2,263 -0.9% 94.75 US$214,410
2026-07-01 2026-07-01 PlS Planned sale
0.6
Sandler Laura Lee

Chief Operating Officer

Officer
2,237 -0.9%
93.85
US$209,933 		2,237 -0.9% 93.85 US$209,933
2026-06-22 2026-06-22 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
699 -4.4%
82.15
US$57,419 		699 -4.4% 82.15 US$57,419
2026-06-22 2026-06-22 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
699 -4.4%
82.15
US$57,419 		699 -4.4% 82.15 US$57,419
2026-06-22 2026-06-22 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
888 -5.3%
80.01
US$71,049 		888 -5.3% 80.01 US$71,049
2026-06-22 2026-06-22 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
888 -5.3%
80.01
US$71,049 		888 -5.3% 80.01 US$71,049
2026-06-15 2026-06-15 S Sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
395 -2.3%
69.69
US$27,528 		395 -2.3% 69.69 US$27,528
2026-06-15 2026-06-15 S Sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
947 -2.8%
69.69
US$65,996 		947 -2.8% 69.69 US$65,996
2026-06-15 2026-06-15 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
300 -0.9%
70.62
US$21,187 		300 -0.9% 70.62 US$21,187
2026-06-15 2026-06-15 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
5,064 -13.0%
69.42
US$351,547 		5,064 -13.0% 69.42 US$351,547
2026-06-15 2026-06-15 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
1,636 -4.0%
68.38
US$111,876 		1,636 -4.0% 68.38 US$111,876
2026-06-15 2026-06-15 S Sale
0.6
Klein Lawrence Otto

Chief Executive Officer

Executive Director
1,729 -0.2%
69.69
US$120,494 		1,729 -0.2% 69.69 US$120,494
2026-06-15 2026-06-15 S Sale
0.6
Sandler Laura Lee

Chief Operating Officer

Officer
600 -0.3%
69.69
US$41,814 		600 -0.3% 69.69 US$41,814
2026-06-15 2026-06-15 S Sale
0.6
Quinlan Paul T

General Counsel

Officer
733 -2.3%
69.69
US$51,083 		733 -2.3% 69.69 US$51,083
2026-06-15 2026-06-12 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
3,260 -15.9%
70.34
US$229,306 		3,260 -15.9% 70.34 US$229,306
2026-06-15 2026-06-12 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
4,340 -17.4%
69.85
US$303,154 		4,340 -17.4% 69.85 US$303,154
2026-06-15 2026-06-12 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
1,859 -6.9%
68.34
US$127,048 		1,859 -6.9% 68.34 US$127,048
2026-06-12 2026-06-12 PlS Planned sale
Dambkowski Carl
Non-Executive Director
12,583 -24.5%
70.11
US$882,182 		12,583 -24.5% 70.11 US$882,182
2026-06-12 2026-06-12 PlS Planned sale
Dambkowski Carl
Non-Executive Director
12,583 -24.5%
70.11
US$882,182 		12,583 -24.5% 70.11 US$882,182
2026-06-12 2026-06-11 PlS Planned sale
Dambkowski Carl
Non-Executive Director
22,417 -30.4%
70.13
US$1,572,201 		22,417 -30.4% 70.13 US$1,572,201
2026-06-11 2026-06-11 PrS Proposed sale
CARL DAMBKOWSKI

Director

Non-Executive Director
35,000
64.03
US$2,241,050 		35,000 64.03 US$2,241,050
2026-06-11 2026-06-11 PrS Proposed sale
CARL DAMBKOWSKI

Director

Non-Executive Director
35,000
64.03
US$2,241,050 		35,000 64.03 US$2,241,050
2026-05-22 2026-05-21 PlS Planned sale
Dambkowski Carl
Non-Executive Director
13,235 -15.2%
59.97
US$793,662 		13,235 -15.2% 59.97 US$793,662
2026-05-22 2026-05-21 PlS Planned sale
Dambkowski Carl
Non-Executive Director
53,447 -38.1%
59.10
US$3,158,910 		53,447 -38.1% 59.10 US$3,158,910
2026-05-22 2026-05-21 PlS Planned sale
Dambkowski Carl
Non-Executive Director
38,318 -21.4%
58.43
US$2,238,794 		38,318 -21.4% 58.43 US$2,238,794
2026-05-21 2026-05-21 PrS Proposed sale
CARL DAMBKOWSKI

Director

Non-Executive Director
105,000
60.67
US$6,370,350 		105,000 60.67 US$6,370,350
2026-05-21 2026-05-21 PrS Proposed sale
CARL DAMBKOWSKI

Director

Non-Executive Director
105,000
60.67
US$6,370,350 		105,000 60.67 US$6,370,350
2026-05-18 2026-05-18 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
700 -4.1%
61.16
US$42,812 		700 -4.1% 61.16 US$42,812
2026-05-18 2026-05-18 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
800 -4.5%
60.34
US$48,269 		800 -4.5% 60.34 US$48,269
2026-05-18 2026-05-18 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
4,600 -20.4%
59.19
US$272,260 		4,600 -20.4% 59.19 US$272,260
2026-05-18 2026-05-18 PlS Planned sale
0.6
Agarwal Arjun

Senior Vice President, Finance

Officer
4,190 -15.7%
58.34
US$244,465 		4,190 -15.7% 58.34 US$244,465
2026-05-18 2026-05-18 PrS Proposed sale
0.6
ARJUN AGARWAL

Officer

Officer
22,206
61.93
US$1,375,218 		22,206 61.93 US$1,375,218
2026-05-15 2026-05-15 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
100 -0.3%
63.52
US$6,352 		100 -0.3% 63.52 US$6,352
2026-05-15 2026-05-15 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
2,100 -5.9%
62.42
US$131,088 		2,100 -5.9% 62.42 US$131,088
2026-05-15 2026-05-15 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
4,800 -11.9%
61.56
US$295,495 		4,800 -11.9% 61.56 US$295,495
2026-05-01 2026-05-01 PlS Planned sale
0.6
Sandler Laura Lee

Chief Operating Officer

Officer
100 -0.0%
68.48
US$6,848 		100 -0.0% 68.48 US$6,848
2026-05-01 2026-05-01 PlS Planned sale
0.6
Sandler Laura Lee

Chief Operating Officer

Officer
200 -0.1%
67.16
US$13,431 		200 -0.1% 67.16 US$13,431
2026-05-01 2026-05-01 PlS Planned sale
0.6
Sandler Laura Lee

Chief Operating Officer

Officer
400 -0.2%
66.06
US$26,422 		400 -0.2% 66.06 US$26,422
2026-05-01 2026-05-01 PlS Planned sale
0.6
Sandler Laura Lee

Chief Operating Officer

Officer
300 -0.1%
65.10
US$19,530 		300 -0.1% 65.10 US$19,530
2026-05-01 2026-05-01 PlS Planned sale
0.6
Sandler Laura Lee

Chief Operating Officer

Officer
1,800 -0.8%
64.15
US$115,468 		1,800 -0.8% 64.15 US$115,468
2026-05-01 2026-05-01 PlS Planned sale
0.6
Sandler Laura Lee

Chief Operating Officer

Officer
2,200 -0.9%
62.58
US$137,685 		2,200 -0.9% 62.58 US$137,685
2026-05-01 2026-05-01 PrS Proposed sale
0.6
LAURA SANDLER

Officer

Officer
10,000
68.41
US$684,100 		10,000 68.41 US$684,100
2026-04-15 2026-04-15 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
500 -1.5%
67.38
US$33,692 		500 -1.5% 67.38 US$33,692
2026-04-15 2026-04-15 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
2,273 -6.3%
66.56
US$151,301 		2,273 -6.3% 66.56 US$151,301
2026-04-15 2026-04-15 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
4,227 -10.5%
65.73
US$277,837 		4,227 -10.5% 65.73 US$277,837
2026-04-15 2026-04-15 PrS Proposed sale
0.6
JOANA GONCALVES

Officer

Officer
21,000
67.06
US$1,408,260 		21,000 67.06 US$1,408,260
Explore more

More insider trading research around Oruka Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America